Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
BHV-1300
DRUG
2 trials
Sponsors
Biohaven Therapeutics Ltd.
Conditions
Graves Disease
Phase 1
Study of BHV-1300 in Graves' Disease
Recruiting
NCT06980649
Biohaven Therapeutics Ltd.
Graves Disease
Start: 2025-08-21
End: 2027-09-01
Target: 15
Updated: 2026-07-31
Phase 3
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Recruiting
NCT07661056
Biohaven Therapeutics Ltd.
Graves Disease
Start: 2026-06-26
End: 2028-02-01
Target: 300
Updated: 2026-09-17